Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRH reversal of remifentanil-induced respiratory depression in healthy volunteers
NL-OMON46759Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of thyrotropin-releasing hormone and remifentanil in opioid-induced respiratory depression (OIRD), sponsored by Leiden University Medical Center. Primary endpoint: Ventilation. Started Apr 2018; status: active, not recruiting.
02
Drugs
thyrotropin-releasing hormoneremifentanil
03
Conditions
opioid-induced respiratory depression (OIRD)
Beyond the preview
Go deeper on NL-OMON46759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46759.